ClinicalTrials.gg

Drug

Teicoplanin clinical trials

studies test it
11
open now
0
in phase 3
1
first study started
1999

How studies write it

Studies that test it under each name

Name

Teicoplanin
11

Brand

Targocid
1

Studies by the year they started

11 studies that test it; most in 2020 (2)

Studies that test Teicoplanin, by start year
YearStudies
19991
20041
20051
20061
20111
20131
20191
20202
20211
20231

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 3 · Other 8

Sanofi (2) · Centre Hospitalier Universitaire, Amiens (1) · Tongji Hospital (1) · Neupharma Srl (1) · University of Athens (1) · Radboud University Medical Center (1) · Bezmialem Vakif University (1) · Children's Cancer and Leukaemia Group (1)

Often tested with

Tested in the same studies.

Vancomycin (2) · Sulperazone (1) · Linezolid (1)

Studies

Open first, then newest update. How each study uses Teicoplanin is read from its arms, and is right about nine times in ten.

Testing it · 11

Given in every arm · 2 — Teicoplanin is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Teicoplanin

Codes

What other systems call Teicoplanin · ClinicalTrials.gg INT008590

  • MeSH (NLM) D017334TeicoplaninOne source ClinicalTrials.gov
  • UNII (FDA) 4U3D3YY81MTEICOPLANINOne source FDA
  • RxNorm 57021One source FDA
  • NCI Thesaurus C1412TeicoplaninOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.